Lisata Therapeutics, Inc.
LSTA
$1.09
-$0.04-3.54%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 37.13% | 4.97% | 35.92% | 13.81% | 7.63% |
| Total Depreciation and Amortization | -93.18% | -95.35% | -63.41% | 4.76% | -2.22% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.28% | -25.56% | 53.24% | -18.05% | 110.58% |
| Change in Net Operating Assets | -85.68% | 185.95% | -125.63% | -69.34% | 213.40% |
| Cash from Operations | 33.04% | 42.93% | 28.25% | -32.72% | 25.12% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -100.00% | 181.68% | -95.69% |
| Cash from Investing | -- | -- | -100.00% | 181.68% | -95.69% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -60.81% | 54.55% | 469.44% | -- | 131.25% |
| Repurchase of Common Stock | 100.00% | 34.57% | 100.00% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -54.69% | 886.96% | 313.54% | -- | 100.00% |
| Foreign Exchange rate Adjustments | -40.00% | 200.00% | 103.08% | -94.87% | -80.77% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 22.62% | -172.26% | 7.82% | 124.62% | -152.13% |